Wisteriagen LLC is a Japanese biotech company pioneering drug discovery through regulation of gene expression. The company develops platform technologies including locus-specific ChIP (chromatin immunoprecipitation) for drug target discovery and ORNi-PCR for detecting rare DNA sequence mutations. Wisteriagen is a research-stage biotech focused on internal drug discovery, not a contract manufacturer.
epigenetic drug target discovery, locus-specific ChIP technology, ORNi-PCR rare mutation detection, gene expression regulation
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.